Monkeypox clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
San Francisco, California and other locations